DIELLA, LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 1.462
EU - Europa 744
AS - Asia 733
SA - Sud America 160
Continente sconosciuto - Info sul continente non disponibili 108
AF - Africa 39
OC - Oceania 2
Totale 3.248
Nazione #
US - Stati Uniti d'America 1.370
SG - Singapore 355
IT - Italia 318
BR - Brasile 111
CN - Cina 103
DE - Germania 100
HK - Hong Kong 83
RU - Federazione Russa 83
VN - Vietnam 59
FR - Francia 58
CA - Canada 45
GB - Regno Unito 35
FI - Finlandia 33
BD - Bangladesh 32
SE - Svezia 31
NL - Olanda 20
MX - Messico 18
CI - Costa d'Avorio 17
ID - Indonesia 15
AR - Argentina 14
ES - Italia 14
IN - India 12
PL - Polonia 12
CO - Colombia 11
PH - Filippine 11
IQ - Iraq 9
LT - Lituania 9
PK - Pakistan 9
TR - Turchia 9
VE - Venezuela 9
ZA - Sudafrica 9
UA - Ucraina 8
CZ - Repubblica Ceca 7
EC - Ecuador 6
SV - El Salvador 6
JO - Giordania 5
MA - Marocco 5
SA - Arabia Saudita 5
CL - Cile 4
GT - Guatemala 4
HN - Honduras 4
TT - Trinidad e Tobago 4
AT - Austria 3
JP - Giappone 3
NP - Nepal 3
TN - Tunisia 3
AU - Australia 2
AZ - Azerbaigian 2
CH - Svizzera 2
CR - Costa Rica 2
IE - Irlanda 2
JM - Giamaica 2
KE - Kenya 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
NI - Nicaragua 2
PE - Perù 2
PS - Palestinian Territory 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AL - Albania 1
BE - Belgio 1
BY - Bielorussia 1
BZ - Belize 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GP - Guadalupe 1
IL - Israele 1
IM - Isola di Man 1
IR - Iran 1
KG - Kirghizistan 1
MY - Malesia 1
MZ - Mozambico 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
TH - Thailandia 1
UY - Uruguay 1
Totale 3.141
Città #
Singapore 226
Ashburn 223
San Jose 180
Hong Kong 82
Milan 69
Council Bluffs 60
Los Angeles 53
Beijing 49
Rome 48
Santa Clara 44
New York 43
Munich 40
Falkenstein 29
Columbus 28
Lauterbourg 28
Boardman 26
Dallas 26
Nyköping 24
Helsinki 23
Buffalo 22
Phoenix 22
Chandler 21
Chicago 20
Bari 19
Abidjan 17
Frankfurt am Main 17
Ho Chi Minh City 16
São Paulo 14
Montreal 12
Brooklyn 11
London 11
Toronto 11
Atlanta 10
Hanoi 10
Turku 10
Jakarta 9
Moscow 9
Turin 9
Warsaw 9
Mexico City 8
Brno 7
Houston 7
Orem 7
San Diego 7
Stockholm 7
Charlotte 6
Detroit 6
Düsseldorf 6
Rio de Janeiro 6
San Salvador 6
Tampa 6
Brasília 5
Figino 5
Medellín 5
Naples 5
Nuremberg 5
Palermo 5
Salt Lake City 5
Seattle 5
Washington 5
Amman 4
Bologna 4
City of London 4
Curitiba 4
Da Nang 4
Denver 4
Johannesburg 4
Marseille 4
Monza 4
North Bergen 4
Poplar 4
San Francisco 4
Bogotá 3
Caracas 3
Catania 3
Chennai 3
Contagem 3
Fairfield 3
Guatemala City 3
Haiphong 3
Lahore 3
Lucca 3
Manila 3
Ottawa 3
Querétaro 3
Redondo Beach 3
Rosà 3
Tegucigalpa 3
The Bronx 3
Tokyo 3
Toledo 3
Wilmington 3
Woodbridge 3
Wroclaw 3
Angri 2
Asunción 2
Aversa 2
Avon 2
Baghdad 2
Baltimore 2
Totale 1.830
Nome #
Lung Ultrasound Is Useful for Evaluating Lung Damage in COVID-19 Patients Treated with Bamlanivimab and Etesevimab: A Single-Center Pilot Study 185
Cefiderocol-Based Combination Therapy for "Difficult-to-Treat" Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives 169
Cefiderocol Versus Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii Complex Bloodstream Infections: A Retrospective, Propensity-Score Adjusted, Monocentric Cohort Study 162
Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection 153
A Challenging Case of Visceral Leishmaniasis 149
Impact of a Multistep Bundles Intervention in the Management and Outcome of Gram-Negative Bloodstream Infections: A Single-Center "Proof-of-Concept" Study 134
Recurrent neurosurgical site infection by extensively drug-resistant P. aeruginosa treated with cefiderocol: a case report and literature review 129
Effectiveness of First-Line Therapy with Old and Novel Antibiotics in Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant Acinetobacter baumannii: A Real Life, Prospective, Observational, Single-Center Study 128
Efficacy of Remdesivir and Neutralizing Monoclonal Antibodies in Monotherapy or Combination Therapy in Reducing the Risk of Disease Progression in Elderly or Immunocompromised Hosts Hospitalized for COVID-19: A Single Center Retrospective Study 119
Analysis of Italian requests for compensation in cases of responsibility for healthcare-related infections: A retrospective study 116
Meropenem/Vaborbactam Plus Aztreonam as a Possible Treatment Strategy for Bloodstream Infections Caused by Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae: A Retrospective Case Series and Literature Review 112
Prompt and Appropriate Antimicrobial Therapy Improves Outcomes of NDM-Producing and KPC-Producing Klebsiella pneumoniae Bloodstream Infections in Patients Hospitalized for COVID-19: A Comparative Retrospective Case-Series 111
Loading dose plus continuous/extended infusion versus intermittent bolus of β-lactams for the treatment of Gram-negative bacteria bloodstream infections: a propensity score-adjusted retrospective cohort study 111
Beyond the distance between juridic and scientific decision-making process: An evidence-based prediction algorithm for professional liability assessment in healthcare-associated infections 105
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 102
Peculiar clinical presentation of COVID-19 and predictors of mortality in the elderly: A multicentre retrospective cohort study 101
Impact of a Pro-Active Infectious Disease Consultation on the Management of a Multidrug-Resistant Organisms Outbreak in a COVID-19 Hospital: A Three-Months Quasi-Experimental Study 101
Association of piperacillin/tazobactam MIC and mortality in a cohort of ceftriaxone-resistant Escherichia coli bloodstream infections treated with piperacillin/tazobactam and carbapenems: a multicentric propensity score-weighted observational cohort study 100
Thoracic aorta graft infection by avibactam-resistant KPC-producing K. pneumoniae treated with meropenem/vaborbactam: a case report and literature review 94
Oral anti‐viral therapy for early COVID‐19 infection in patients with haematological malignancies: A multicentre prospective cohort 91
Stigma and mental health among people living with HIV across the COVID-19 pandemic: a cross-sectional study 90
Current therapies for chronic lymphocytic leukemia: risk and prophylaxis strategies for secondary/opportunistic infections 89
Why do echinocandins fail? Identifying key predictors to improve clinical outcomes of candida bloodstream infections: a retrospective multicenter cohort study 83
Incidence and predictors of infections in patients with advanced non‐small cell lung cancer treated with checkpoint inhibitor immunotherapies: A monocentric retrospective cohort study 82
First-line combination therapy with fifth generation cephalosporins plus daptomycin compared to other-antimicrobial-regimens for methicillin-resistant Staphylococcus aureus bacteraemia: a multicenter retrospective cohort study 81
Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patients 71
Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future 65
Intravenous Fosfomycin as Adjunctive Therapy for Gram-Negative Bacteria Bloodstream Infections: A Propensity Score Adjusted Retrospective Cohort Study 60
Guinea Worm Disease: A Neglected Diseases on the Verge of Eradication 60
What Is the Efficacy of Sotrovimab in Reducing Disease Progression and Death in People with COVID-19 during the Omicron Era? Answers from a Real-Life Study 44
Anti–Methicillin-Resistant Staphylococcus aureus (MRSA) Cephalosporins Plus Daptomycin as Initial Therapy for MRSA Bacteremia: Does a “Hit Hard and Fast” Strategy Improve Outcomes? 27
Is early combination therapy associated with lower risk of respiratory failure in severely immunocompromised hosts with COVID-19? a target trial emulation study from the omicron-dominant era 24
Totale 3.248
Categoria #
all - tutte 12.560
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.560


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202214 0 0 0 0 0 1 0 2 2 2 1 6
2022/202386 2 8 2 3 14 13 3 18 12 2 1 8
2023/2024116 10 22 3 13 13 25 0 8 1 1 3 17
2024/2025634 28 16 6 28 20 55 83 76 26 68 78 150
2025/20261.750 209 61 89 186 216 124 169 65 204 174 55 198
2026/2027629 82 142 151 236 18 0 0 0 0 0 0 0
Totale 3.248